Cargando…

Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis

BACKGROUND: Current treatments for osteoporosis are associated with various side effects and do not prevent the age-related decrease in osteoblast number. The objective of this study was to evaluate the effects of iQPR-H(2)O on osteogenesis. METHODS: Mouse fibroblast NIH3T3 and pre-osteoblastic MC3T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chiming, Cheong, Meileng, Hsiao, Wentien, Liu, Henyu, Tsai, Chingyu, Wang, Mingfu, Wu, Chihhsiung, Chang, Kwanghwa, Lam, Gowlin, Deng, Winping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206489/
https://www.ncbi.nlm.nih.gov/pubmed/21981964
http://dx.doi.org/10.1186/1471-2474-12-227
_version_ 1782215446146056192
author Lee, Chiming
Cheong, Meileng
Hsiao, Wentien
Liu, Henyu
Tsai, Chingyu
Wang, Mingfu
Wu, Chihhsiung
Chang, Kwanghwa
Lam, Gowlin
Deng, Winping
author_facet Lee, Chiming
Cheong, Meileng
Hsiao, Wentien
Liu, Henyu
Tsai, Chingyu
Wang, Mingfu
Wu, Chihhsiung
Chang, Kwanghwa
Lam, Gowlin
Deng, Winping
author_sort Lee, Chiming
collection PubMed
description BACKGROUND: Current treatments for osteoporosis are associated with various side effects and do not prevent the age-related decrease in osteoblast number. The objective of this study was to evaluate the effects of iQPR-H(2)O on osteogenesis. METHODS: Mouse fibroblast NIH3T3 and pre-osteoblastic MC3T3-E1 cells were cultured in medium prepared with iQPR-H(2)O or unprocessed mineral water (control cells), and proliferation and differentiation were assessed by MTT and alkaline phosphatase assay, respectively. Mineral deposition by the cells was determined using Alizarin red S staining. A mouse model of osteoporosis, ovariectomized SAMP8 mice, was used to evaluate the effects of iQPR-H(2)O on osteogenesis in vivo. Mice were given either iQPR-H(2)O or unprocessed mineral water (control group) for four months after which bone mass density (BMD) measurements were made using a bone densitometer and hematoxylin and eosin staining of bone samples. RESULTS: NIH3T3 cells grown in medium prepared with iQPR-H(2)O exhibited significantly greater proliferation. NIH3T3 and MC3T3-E1 cells demonstrated a significant increase in alkaline phosphatase levels in the iQPR-H(2)O group. MC3T3-E1 cells showed mineralization at day 28. mRNA expression levels of both osteopontin and runt-related transcription factor 2 in MC3T3-E1 cells were higher in the iQPR-H(2)O group compared with the control group. After four months, significantly greater bone regeneration was evident in ovariectomized SAMP8 mice administered iQPR-H(2)O as compared with control group. CONCLUSIONS: iQPR-H(2)O may reduce the symptoms of osteoporosis by improving osteogenesis.
format Online
Article
Text
id pubmed-3206489
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32064892011-11-03 Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis Lee, Chiming Cheong, Meileng Hsiao, Wentien Liu, Henyu Tsai, Chingyu Wang, Mingfu Wu, Chihhsiung Chang, Kwanghwa Lam, Gowlin Deng, Winping BMC Musculoskelet Disord Research Article BACKGROUND: Current treatments for osteoporosis are associated with various side effects and do not prevent the age-related decrease in osteoblast number. The objective of this study was to evaluate the effects of iQPR-H(2)O on osteogenesis. METHODS: Mouse fibroblast NIH3T3 and pre-osteoblastic MC3T3-E1 cells were cultured in medium prepared with iQPR-H(2)O or unprocessed mineral water (control cells), and proliferation and differentiation were assessed by MTT and alkaline phosphatase assay, respectively. Mineral deposition by the cells was determined using Alizarin red S staining. A mouse model of osteoporosis, ovariectomized SAMP8 mice, was used to evaluate the effects of iQPR-H(2)O on osteogenesis in vivo. Mice were given either iQPR-H(2)O or unprocessed mineral water (control group) for four months after which bone mass density (BMD) measurements were made using a bone densitometer and hematoxylin and eosin staining of bone samples. RESULTS: NIH3T3 cells grown in medium prepared with iQPR-H(2)O exhibited significantly greater proliferation. NIH3T3 and MC3T3-E1 cells demonstrated a significant increase in alkaline phosphatase levels in the iQPR-H(2)O group. MC3T3-E1 cells showed mineralization at day 28. mRNA expression levels of both osteopontin and runt-related transcription factor 2 in MC3T3-E1 cells were higher in the iQPR-H(2)O group compared with the control group. After four months, significantly greater bone regeneration was evident in ovariectomized SAMP8 mice administered iQPR-H(2)O as compared with control group. CONCLUSIONS: iQPR-H(2)O may reduce the symptoms of osteoporosis by improving osteogenesis. BioMed Central 2011-10-08 /pmc/articles/PMC3206489/ /pubmed/21981964 http://dx.doi.org/10.1186/1471-2474-12-227 Text en Copyright ©2011 Lee et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lee, Chiming
Cheong, Meileng
Hsiao, Wentien
Liu, Henyu
Tsai, Chingyu
Wang, Mingfu
Wu, Chihhsiung
Chang, Kwanghwa
Lam, Gowlin
Deng, Winping
Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title_full Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title_fullStr Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title_full_unstemmed Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title_short Use of iQPR-H(2)O for bone regeneration and its potential in the improvement of osteoporosis
title_sort use of iqpr-h(2)o for bone regeneration and its potential in the improvement of osteoporosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206489/
https://www.ncbi.nlm.nih.gov/pubmed/21981964
http://dx.doi.org/10.1186/1471-2474-12-227
work_keys_str_mv AT leechiming useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT cheongmeileng useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT hsiaowentien useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT liuhenyu useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT tsaichingyu useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT wangmingfu useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT wuchihhsiung useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT changkwanghwa useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT lamgowlin useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis
AT dengwinping useofiqprh2oforboneregenerationanditspotentialintheimprovementofosteoporosis